CASE STUDIES
Practice Revenue Model
This illustrative model shows how a solo cash-pay wellness clinic can structure its revenue using 503B-sourced compounded medications — and what the economics look like at realistic patient volumes. Use it as a starting framework as you evaluate how 503B sourcing might fit your own practice.
How a solo wellness clinic generates $427K+ net annually with 503B sourcing
Vitality Wellness Clinic scaled a cash-pay weight management and hormone therapy practice using FDA-registered 503B compounded medications — with margins that traditional pharmacy models can’t touch.
Practice type
Cash-pay wellness clinic
Specialties
Weight management, hormone therapy
Monthly patients
150–200 active
Staff
2 full-time (nurse + admin)
AT A GLANCE
Monthly gross revenue
$75,600
180 active patients
Cost of goods
16%<
of total revenue
Monthly net profit
$35,600
to owner/practitioner
Annualized net income
$427K
conservative scenario
PRODUCT ECONOMICS
Revenue by product line
503B wholesale pricing creates wide margins that allow competitive patient pricing while preserving strong clinic economics.
Per-patient monthly economics
| Product | Details |
|---|---|
| Weight-loss injectables | Compounded weekly-dose program; one vial covers 4–8 weeks. 503B cost: $30–$75 / Patient price: $300–$500 / Up to 1,000% margin |
| Testosterone cypionate | TRT multi-dose vial; long shelf life. 503B cost: $15–$50 / Patient price: $135–$250 / Up to 700% margin |
| MIC/B12 & peptides | Add-on upsell; high repeat purchase rate. 503B cost: $20–$60 / Patient price: $80–$150 / Up to 500% margin |
Monthly P&L snapshot
| Product | Details |
|---|---|
| Weight-loss injectables | Compounded weekly-dose program; one vial covers 4–8 weeks. 503B cost: $30–$75 / Patient price: $300–$500 / Up to 1,000% margin |
| Testosterone cypionate | TRT multi-dose vial; long shelf life. 503B cost: $15–$50 / Patient price: $135–$250 / Up to 700% margin |
| MIC/B12 & peptides | Add-on upsell; high repeat purchase rate. 503B cost: $20–$60 / Patient price: $80–$150 / Up to 500% margin |
SCALE SCENARIOS
Net income by patient volume
Break-even sits around 40–60 patients per month. Beyond that, each additional patient adds mostly margin.
Conservative (180 patients)$427K / year
Growth (300 patients + add-ons)$600K–$800K / year
High-volume (300+ patients, IV therapies, memberships) $1M+ / year
KEY DRIVERS
What makes the model work 503B sourcing isn’t just a cost play — it changes the entire unit economics of operating a compounded-medication practice.
Profit levers
- Product markup. 300–1,000%+ on medication cost is standard in cash-pay models when sourcing from 503B wholesale.
- Bundled services. Flat monthly packages ($300–$500) layer in $100–$200 in office visits, labs, and follow-up on top of the med margin.
- Volume leverage. At 100–200 patients, monthly revenue becomes highly predictable with minimal incremental variable cost.
- Low inventory overhead. Stable sterile products, direct-to-clinic shipping, and no per-patient compounding.
Revenue composition
503B product line60–80% of revenue
Service & bundled fees20–40% of revenue
Overall net margin 30–50%
Significantly higher than traditional primary care
“60–80% of total clinic revenue comes from the 503B-sourced product line. Net margins of 30–50% overall — far higher than traditional primary-care practices — are achievable for solo practitioners once the model reaches 100+ active patients.”
RISK CONSIDERATIONS
Factors to build into your planning The model is high-margin, but durable success depends on staying ahead of these variables.
Regulatory changes
FDA updates on specific bulk substances can affect product availability and formulary composition.Telehealth competition
Online-only platforms compete on convenience; local clinics differentiate through in-person care and monitoring.Supply & compliance costs
Sterility testing and compliance investments from your 503B partner may be passed through as pricing shifts.Ready to build this model in your practice?
Connect with FDA-registered 503B facilities through 503bConnect — vetted, cGMP compliant, nationwide.Have Questions? We’re Here to Help.
Have questions about pricing, how it works, or whether 503bConnect is right for your practice? We’d love to hear from you. Fill out the form below and we’ll be in touch.A Note on These Projections
- Illustrative purposes only. The figures, margins, and income projections on this page are based on generalized industry estimates and are provided for informational purposes only. They do not represent guaranteed results, and actual outcomes will vary based on patient volume, geographic market, overhead, product mix, and other factors.
- Not financial or business advice. Nothing on this page constitutes financial, business, or investment advice. Consult qualified legal, financial, and compliance professionals before making decisions about your practice model.
- Regulatory compliance is your responsibility. Prescribing, dispensing, and administering compounded medications is subject to federal and state regulations that vary by jurisdiction. It is the practitioner’s responsibility to ensure full compliance with applicable laws, including state medical board rules, pharmacy regulations, and FDA guidelines.
- 503bConnect is not a pharmacy. 503bConnect does not compound, dispense, or distribute medications. All compounding and fulfillment is performed by independent, FDA-registered 503B outsourcing facilities.
- Product availability may change. The FDA periodically updates its list of approved bulk drug substances. Product availability through 503B facilities is subject to change and should be verified at the time of ordering.